Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease

Authors:
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • EPSRC
  • GlaxoSmithKline Clinical Imaging Center
  • European Union 7th Framework Program, PredictAD, From Patient Data to Personalised Healthcare in Alzheimer's Disease
  • National Institutes of Health (U01 AG024904)
  • National Institute on Aging
  • National Institute of Biomedical Imaging and Bioengineering
  • Abbott
  • AstraZeneca AB
  • Bayer Schering Pharma AG
  • Bristol-Myers Squibb
  • Eisai Global Clinical Development
  • Elan Corporation
  • Genentech
  • GE Healthcare
  • GlaxoSmithKline
  • Innogenetics
  • Johnson and Johnson
  • Eli Lilly and Co.
  • Medpace, Inc.
  • Merck and Co., Inc.
  • Novartis AG
  • Pfizer Inc
  • F. Hoffman-La Roche
  • Schering-Plough
  • Synarc, Inc.
  • Wyeth
  • Alzheimer's Association and Alzheimer's Drug Discovery Foundation
  • U.S. Food and Drug Administration
  • Northern California Institute for Research and Education

This publication has 96 references indexed in Scilit: